Keithaiken (Talk | contribs) |
|||
Line 113: | Line 113: | ||
<br> | <br> | ||
<p> <b><center> Table 2. Canadian and American Regulation Comparisons for Cell-Free Systems. </b> </p> | <p> <b><center> Table 2. Canadian and American Regulation Comparisons for Cell-Free Systems. </b> </p> | ||
+ | <center> | ||
+ | <div id="HPtable1"> | ||
+ | <table style= "#"> | ||
+ | <tr> | ||
+ | <th align= "center">Regulation Area</th> | ||
+ | <th align= "center">Canada </th> | ||
+ | <th align= "center">United States</th> | ||
+ | </tr> | ||
+ | <tr> | ||
+ | <th align= "center">Health</th> | ||
+ | <td align= "center"><i>Assisted Human Reproduction Act</i> (HC): <ul>Focus on IVF and new technologies that can aid in reproduction </ul> <ul> Transplantation into a non-human life form is prohibited </ul> </td> | ||
+ | <td align= "center"><i>Federal Food, Drug, and Cosmetic Act </i> (FDA)<br><i> Public Health Services Act </i> (FDA): <ul> All biological products must go through licensing process before introduction</ul></td> | ||
+ | </tr> | ||
+ | <tr> | ||
+ | <th align= "center">Environment</th> | ||
+ | <td align= "center"><i>Canadian Environmental Protection Act </i> (EC and HC): <ul>Focus on environmental release and new organism activity </ul> <ul> Environmental assessment required and notification of agencies </ul> </td> | ||
+ | <td align= "center"><i>National Environment Policy Act</i> (EPA: <ul> Requires environmental assessments to determine the impact on the environment</ul></td> | ||
+ | </tr> | ||
+ | <tr> | ||
+ | <th align= "center">Food/Pharmaceuticals</th> | ||
+ | <td align= "center"><i>Food and Drugs Act</i> (CFIA): <ul>Focus on labelling and notification of marketing</ul> <ul> Director must receive notification of intent to sell modified products including an extensive report </ul> </td> | ||
+ | <td align= "center"><i>Federal Food, Drug, and Cosmetic Act</i> (FDA)<br><i>Public Health Service Act</i> (FDA) : <ul>Must be approved by FDA if food is an additive, but mislabelled food is prohibited</ul> <ul> New Drug Application submitted for approval to go to marker </ul> </td> | ||
+ | </tr> | ||
+ | <tr> | ||
+ | <th align= "center">Agriculture</th> | ||
+ | <td align= "center"><i>Seeds Act</i> (CFIA) <br> <i>Canada Agricultural Products Act </i> (CFIA): <ul>Planting, importation, and transportation regulated</ul> <ul> Must have proof to not cause harm to humans or the environment </ul> </td> | ||
+ | <td align= "center"><i>Agricultural Act Federal Seed Act </i> (APHIS)<br><i>Plant Protection Act</i> (APHIS) : <ul>Planting, importation, and transportation regulated</ul> <ul> Must have approval before plant is introduced </ul> </td> | ||
+ | </tr> | ||
+ | <tr> | ||
+ | <th align= "center">Pests</th> | ||
+ | <td align= "center"><i>Pest Control Act</i> (PMRA): <ul>Accepted if there is proof that no human health will not be affected or will have long term effects on the environment </ul> </td> | ||
+ | <td align= "center"><i>Federal Insecticide, Fungicide, and Rodenticide Act </i> (EPA): <ul>Registration process detailing proof no harm to the environment</ul> </td> | ||
+ | </tr> | ||
+ | <tr> | ||
+ | <th align= "center">Microorganisms</th> | ||
+ | <td align= "center"><i>Canadian Environmental Protection Act </i> (EC and HC): <ul>Undergo screening assessment to identify potential harm to humans and the environment </ul> </td> | ||
+ | <td align= "center"><i>Toxic Substances Control Act</i> (EPA): <ul>Must submit notice of use with information on organism</ul> </td> | ||
+ | </tr> | ||
+ | <tr> | ||
+ | <th align= "center">Animals</th> | ||
+ | <td align= "center"><i>Health of Animals Regulations</i> (CFIA): <ul>Prohibited to introduce substances without permit</ul> </td> | ||
+ | <td align= "center">New Animal Drug Application (FDA): <ul>Focusses more on drug use</ul> <ul>Must fill out application detailing effects on the animal and the environment</ul></td> | ||
+ | </tr> | ||
+ | <tr> | ||
+ | <th align= "center">Pathogens and Toxins</th> | ||
+ | <td align= "center"><i>Human Pathogens and Toxins Act</i> (PHAC): <ul>Regulates Risk Group 2-4 organisms</ul><ul> Prohibited from producing toxins and pathogens within Schedules without a licence</ul> </td> | ||
+ | <td align= "center"><i>Toxic Substances Control Act</i> (EPA): <ul>Does not classify toxic and non-toxic chemicals</ul> <ul>Chemicals not on list are prohibited from being produced</ul></td> | ||
+ | </tr> | ||
+ | </table> | ||
<br><br><br><br><br><br><br><br><br><br> | <br><br><br><br><br><br><br><br><br><br> | ||
Revision as of 16:59, 28 October 2017
Insert Paragraph Discussing What we did and why
Protocol Simplification
Experimental Design
Professional Development
Regulation Research
Legal System | Civil | Common | Mixed | Religious |
---|---|---|---|---|
Laboratory Safety | General guidelines implemented, national frameworks being updated |
General guidelines implemented in regulations, committees in place to oversee concerns |
General guidelines implemented in regulations, committees in place to oversee concerns |
National biosafety frameworks in the process of being developed, have signed the Cartagena Protocol |
GMO Regulations | In place, appropriate labelling required in most cases to identify GMO status Generally strict regulations in place (EU, JPN) |
In place, usage differs depending on country though most countries allow (notable exception: NZ) |
Dependent on country: some follow EU regulations and restrict access while others are in the process of developing legislation with minimal regulations currently |
In place, only allow certain crops, need proper labelling to identify GMO status |
Environmental Regulations | Environmental impact assessments used to determine effect on biological diversity, environmental release addressed |
Environmental impact assessments used to determine effect on biological diversity, environmental release addressed |
Environmental impact assessments used to determine effect on biological diversity, some countries have in place environmental release stipulations |
Environmental impact assessments used to determine effect on biological diversity, developing more specific legislation for environmental release |
Agricultural Regulations | Regulations mostly relate to field trials | Must be approved by regulatory body to not cause a negative impact on the environment |
Dependent on country: some have strict regulations on crops that can be planted while others have regulations in place, but allow a greater crop diversity |
Regulations relate to type of crops that can be planted |
Health Regulations | Must be approved by governing authority to not have negative impacts | Must be approved by governing authority to not have negative impacts | Must be approved by governing authority to not have negative impacts, some countries are still in the process of developing legislation |
In development with the growth of biotechnology, general regulations state that new materials generated must be approved |
Regulation Area | Canada | United States |
---|---|---|
Health | Assisted Human Reproduction Act (HC):
|
Federal Food, Drug, and Cosmetic Act (FDA) Public Health Services Act (FDA):
|
Environment | Canadian Environmental Protection Act (EC and HC):
|
National Environment Policy Act (EPA:
|
Food/Pharmaceuticals | Food and Drugs Act (CFIA):
|
Federal Food, Drug, and Cosmetic Act (FDA) Public Health Service Act (FDA) :
|
Agriculture | Seeds Act (CFIA) Canada Agricultural Products Act (CFIA):
|
Agricultural Act Federal Seed Act (APHIS) Plant Protection Act (APHIS) :
|
Pests | Pest Control Act (PMRA):
|
Federal Insecticide, Fungicide, and Rodenticide Act (EPA):
|
Microorganisms | Canadian Environmental Protection Act (EC and HC):
|
Toxic Substances Control Act (EPA):
|
Animals | Health of Animals Regulations (CFIA):
|
New Animal Drug Application (FDA):
|
Pathogens and Toxins | Human Pathogens and Toxins Act (PHAC):
|
Toxic Substances Control Act (EPA):
|
System Safety Features
The exploration of our plan on how to address the genetic re-coding aspect of our project continues more in depth on our software page. We consider it to be a major part of our human practices, but to explain it as in depth as it requires, we felt it deserved its own page.